Nanjing Vazyme Biotech Co., Ltd (SHA:688105)

Nanjing Vazyme Biotech Statistics

Total Valuation

SHA:688105 has a market cap or net worth of CNY 8.62 billion. The enterprise value is 6.76 billion.

Market Cap	8.62B
Enterprise Value	6.76B

Important Dates

The next estimated earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688105 has 397.73 million shares outstanding. The number of shares has decreased by -7.51% in one year.

Current Share Class	397.73M
Shares Outstanding	397.73M
Shares Change (YoY)	-7.51%
Shares Change (QoQ)	+50.23%
Owned by Insiders (%)	12.90%
Owned by Institutions (%)	8.92%
Float	117.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	162.53
PS Ratio	6.41
PB Ratio	2.24
P/TBV Ratio	2.38
P/FCF Ratio	75.51
P/OCF Ratio	55.66
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-227.98
EV / Sales	5.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	59.19

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.22.

Current Ratio	3.73
Quick Ratio	3.30
Debt / Equity	0.22
Debt / EBITDA	110.58
Debt / FCF	7.55
Interest Coverage	-5.51

Financial Efficiency

Return on equity (ROE) is -0.85% and return on invested capital (ROIC) is -6.40%.

Return on Equity (ROE)	-0.85%
Return on Assets (ROA)	-1.62%
Return on Invested Capital (ROIC)	-6.40%
Return on Capital Employed (ROCE)	-3.19%
Revenue Per Employee	468,919
Profits Per Employee	-10,337
Employee Count	2,754
Asset Turnover	0.27
Inventory Turnover	1.15

Taxes

Income Tax	-33.66M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.15% in the last 52 weeks. The beta is 0.89, so SHA:688105's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+9.15%
50-Day Moving Average	21.52
200-Day Moving Average	22.83
Relative Strength Index (RSI)	56.39
Average Volume (20 Days)	2,629,624

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688105 had revenue of CNY 1.34 billion and -29.64 million in losses. Loss per share was -0.09.

Revenue	1.34B
Gross Profit	908.04M
Operating Income	-128.57M
Pretax Income	-66.58M
Net Income	-29.64M
EBITDA	-34.78M
EBIT	-128.57M
Loss Per Share	-0.09

Balance Sheet

The company has 2.72 billion in cash and 861.49 million in debt, with a net cash position of 1.86 billion or 4.68 per share.

Cash & Cash Equivalents	2.72B
Total Debt	861.49M
Net Cash	1.86B
Net Cash Per Share	4.68
Equity (Book Value)	3.84B
Book Value Per Share	10.49
Working Capital	2.68B

Cash Flow

In the last 12 months, operating cash flow was 154.86 million and capital expenditures -40.72 million, giving a free cash flow of 114.14 million.

Operating Cash Flow	154.86M
Capital Expenditures	-40.72M
Free Cash Flow	114.14M
FCF Per Share	0.29

Margins

Gross margin is 67.54%, with operating and profit margins of -9.56% and -2.20%.

Gross Margin	67.54%
Operating Margin	-9.56%
Pretax Margin	-4.95%
Profit Margin	-2.20%
EBITDA Margin	-2.59%
EBIT Margin	-9.56%
FCF Margin	8.49%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.39%.

Dividend Per Share	0.30
Dividend Yield	1.39%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	7.51%
Shareholder Yield	8.91%
Earnings Yield	-0.34%
FCF Yield	1.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688105 has an Altman Z-Score of 5.87 and a Piotroski F-Score of 4.

Altman Z-Score	5.87
Piotroski F-Score	4